<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gack MU</submitter><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>3220-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2838087</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>84(7)</volume><pubmed_abstract>Recognition of invading viruses by the host is elicited by cellular sensors which trigger signaling cascades that lead to type I interferon (IFN) gene expression. Retinoic acid-inducible gene I (RIG-I) has emerged as a key receptor for the detection of viral RNA in the cytosol, inducing IFN-mediated innate immune responses to limit viral replication through its interaction with MAVS (also called IPS-1, CARDIF, or VISA). Upon the recognition of viral RNA, the Lys-172 residue of RIG-I undergoes ubiquitination induced by tripartite motif protein 25 (TRIM25), an essential protein for antiviral signal transduction. Here we demonstrate that phosphorylation represents another regulatory mechanism for RIG-I-mediated antiviral activity. Using protein purification and mass spectrometry analysis, we identified three phosphorylation sites in the amino-terminal caspase recruitment domains (CARDs) of RIG-I. One of these residues, Thr-170, is located in close proximity to Lys-172, and we speculated that its phosphorylation may affect Lys-172 ubiquitination and functional activation of RIG-I. Indeed, a RIG-I mutant carrying a phosphomimetic Glu residue in place of Thr-170 loses TRIM25 binding, Lys-172 ubiquitination, MAVS binding, and downstream signaling ability. This suggests that phosphorylation of RIG-I at Thr-170 inhibits RIG-I-mediated antiviral signal transduction. Immunoblot analysis with a phospho-specific antibody showed that the phosphorylation of the RIG-I Thr-170 residue is present under normal conditions but rapidly declines upon viral infection. Our results indicate that Thr-170 phosphorylation and TRIM25-mediated Lys-172 ubiquitination of RIG-I functionally antagonize each other. While Thr-170 phosphorylation keeps RIG-I latent, Lys-172 ubiquitination enables RIG-I to form a stable complex with MAVS, thereby inducing IFN signal transduction.</pubmed_abstract><journal>Journal of virology</journal><pubmed_title>Phosphorylation-mediated negative regulation of RIG-I antiviral activity.</pubmed_title><pmcid>PMC2838087</pmcid><funding_grant_id>U19 AI083025</funding_grant_id><funding_grant_id>HHSN266200700010C</funding_grant_id><funding_grant_id>R01AI46954</funding_grant_id><funding_grant_id>P51 RR000168</funding_grant_id><funding_grant_id>R01 AI046954</funding_grant_id><funding_grant_id>R01 CA082057</funding_grant_id><funding_grant_id>U19AI083025</funding_grant_id><funding_grant_id>R01 AI087846</funding_grant_id><funding_grant_id>K26 RR000168</funding_grant_id><funding_grant_id>R01 AI083355</funding_grant_id><funding_grant_id>RR00168</funding_grant_id><funding_grant_id>AI083355</funding_grant_id><funding_grant_id>CA082057</funding_grant_id><pubmed_authors>Gack MU</pubmed_authors><pubmed_authors>Garcia-Sastre A</pubmed_authors><pubmed_authors>Jung JU</pubmed_authors><pubmed_authors>Nistal-Villan E</pubmed_authors><pubmed_authors>Inn KS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phosphorylation-mediated negative regulation of RIG-I antiviral activity.</name><description>Recognition of invading viruses by the host is elicited by cellular sensors which trigger signaling cascades that lead to type I interferon (IFN) gene expression. Retinoic acid-inducible gene I (RIG-I) has emerged as a key receptor for the detection of viral RNA in the cytosol, inducing IFN-mediated innate immune responses to limit viral replication through its interaction with MAVS (also called IPS-1, CARDIF, or VISA). Upon the recognition of viral RNA, the Lys-172 residue of RIG-I undergoes ubiquitination induced by tripartite motif protein 25 (TRIM25), an essential protein for antiviral signal transduction. Here we demonstrate that phosphorylation represents another regulatory mechanism for RIG-I-mediated antiviral activity. Using protein purification and mass spectrometry analysis, we identified three phosphorylation sites in the amino-terminal caspase recruitment domains (CARDs) of RIG-I. One of these residues, Thr-170, is located in close proximity to Lys-172, and we speculated that its phosphorylation may affect Lys-172 ubiquitination and functional activation of RIG-I. Indeed, a RIG-I mutant carrying a phosphomimetic Glu residue in place of Thr-170 loses TRIM25 binding, Lys-172 ubiquitination, MAVS binding, and downstream signaling ability. This suggests that phosphorylation of RIG-I at Thr-170 inhibits RIG-I-mediated antiviral signal transduction. Immunoblot analysis with a phospho-specific antibody showed that the phosphorylation of the RIG-I Thr-170 residue is present under normal conditions but rapidly declines upon viral infection. Our results indicate that Thr-170 phosphorylation and TRIM25-mediated Lys-172 ubiquitination of RIG-I functionally antagonize each other. While Thr-170 phosphorylation keeps RIG-I latent, Lys-172 ubiquitination enables RIG-I to form a stable complex with MAVS, thereby inducing IFN signal transduction.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Apr</publication><modification>2024-11-12T14:40:38.267Z</modification><creation>2019-03-27T00:29:21Z</creation></dates><accession>S-EPMC2838087</accession><cross_references><pubmed>20071582</pubmed><doi>10.1128/JVI.02241-09</doi><doi>10.1128/jvi.02241-09</doi></cross_references></HashMap>